CD19/CD22 CAR-T Cells in Adults With R/R ALL or NHL

Clinical trial NCT06445803 · RECRUITING

Trial details

NCT number: NCT06445803
Sponsor: Rong Tao
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia, in Relapse Acute Lymphoblastic Leukemia With Failed Remission B-cell Lymphoma Refractory B-cell Lymphoma Recurrent

Start date: 2024-05-31
Primary completion: 2026-10-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.